GD-3 Session III: Medications and Lasers
About this Session
Session Moderators: Deborah G Ristvedt, DO, ABO,
Robert J. Noecker, MD, MBA, ABO
Presentations in this Session
-
Part 1: Medications - New Kids on the Block Part 1: New Meds
Joey Hsia, MD, ABO
-
Part 1: Medications - New Kids on the Block Part 2: New Deliveries
Ahmad A. Aref, MD, MBA, ABO
-
Part 1: Medications - Mix It up: The Role of Fixed Combination and Compounded Therapies
Roma P. Patel, MD, MBA
-
Part 2: Lasers: Is SLT First Line Therapy? - Pro: Light Trial and Other Evidence
Robert J. Noecker, MD, MBA, ABO
-
Part 2: Lasers: Is SLT First Line Therapy? - Con: Meds Should Come First
Kuldev Singh, MD, ABO
-
Part 2: Lasers: Is SLT First Line Therapy? - Case Studies
Robert J. Noecker, MD, MBA, ABO
-
Part 3: The Changing Paradigm for Glaucoma Therapy - Is There a Role for Cycloablation in Early-to-Moderate Glaucoma?
David Sola-Del Valle, MD
-
Part 3: The Changing Paradigm for Glaucoma Therapy - up in Smoke: Role of Marijuana in Glaucoma Treatment
Sameh Mosaed, MD, ABO